Touchstone Innovations is a venture capital firm that focuses on creating, building, and investing in pioneering technology companies emerging from exceptional scientific research in the 'Golden Triangle' of London, Cambridge, and Oxford. Established in 1986, the firm employs a comprehensive strategy that encompasses the entire process from idea generation to intellectual property protection, company formation, seed funding, incubation, and scale-up. By providing continuous investment from start-up to scale-up, Touchstone Innovations supports scientists and entrepreneurs in commercializing their ideas through licensing and recruitment of top management teams. The firm has a proven track record of leveraging early-stage research into high-quality, well-managed businesses, maintaining active involvement with its portfolio companies throughout their lifecycle. With a commitment to de-risking investment, Touchstone Innovations has facilitated over £1.5 billion in funding to drive technological innovation in the UK. In 2017, the firm was acquired by IP Group plc, further expanding its capabilities in the investment landscape.
AccelerComm is an exciting semiconductor IP-core company that provides solutions to accelerate the next generations of wireless communications (3GPP rel 14, rel 15 and beyond). Their technology solves the bottleneck that would otherwise limit the speed of next generation wireless communication, namely the error correction decoding that is required to overcome the effects of noise, interference and poor signal strength.
Re:infer, the Conversational Data Intelligence platform built for the enterprise. Businesses use our platform to optimise customer experience, increase scalability, and improve governance and control. We democratise the power of NLU to transform service. Operated via a zero-code user interface Re:infer allows business, domain experts, and COE developers to create ML or NLP models quickly and at scale. Re:infer is a spinout from UCL, a global centre for artificial intelligence research, is backed by Seedcamp Europe's leading early stage investment fund and some of Europe’s most successful AI entrepreneurs.
SAM Labs provides everything you need to deliver the most engaging STEAM learning experience to your classroom. It seamlessly connects software and hardware with lesson plans that cover a wide variety of subjects, making learning about coding accessible, experimental, interactive and fun. SAM Labs kits are bursting with wireless electronic blocks that each have a personality of their own. From lights to motors to sliders to buzzers, every Bluetooth-enabled block can connect to the others via the app to do something different. Press a button to turn a light on! Use a light sensor to activate an alarm! With the app, students can code the behaviours of blocks in any way they can imagine, enabling them to make anything from simple reactions to complex creations in minutes. Students can use SAM Labs to design, write and debug programs, applying sequencing, selection and iteration. They will use logical reasoning to write algorithms, incorporating variables, inputs and outputs. Using the blocks and app, they will learn to control and simulate physical systems.
Oxford Biotrans Ltd is committed to commercialising new enzymatic routes to high value speciality chemicals based on its patented cytochrome P450 enzyme technology. The company is supported by over 15 years of research by Dr Luet Lok Wong from the Department of Chemistry at the University of Oxford. The first products to market will be flavours and fragrances. The technology also has applications in the production of pheromones, pharmaceuticals and other speciality chemicals.
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.
WaveOptics is a designer and manufacturer of diffractive waveguides for wearable Augmented Reality (AR) devices. The company aims to be the key optical component in wearable augmented reality devices. WaveOptics was founded in 2014 and is headquartered in Abingdon, Oxfordshire.
Yoyo Wallet is a U.K.-based mobile wallet startup that enables its users to pay for their goods with their smartphones. The company currently processes over 150,000 monthly in-store transactions by combining payment and loyalty via an easy scan. It also provides a marketing platform for retailers that enables digital customer engagement in-store. The multi-retailer mobile wallet offers loyalty programs and rewards offerings it can automatically deliver to customers based on buying patterns. Launched in 2013, Yoyo Wallet receives funding from Taavet Hinrikus and TransferWise.
Impression Technologies offer a fully tailored service according to your engineering needs from concept to production. We provide the knowledge and expertise to support HFQ® technology, empowering you to transform your project. Our facility, located in Coventry, UK, is fully equipped to carry out in-house prototyping and production runs to support our HFQ customers and partners.
Concirrus is a leading Insurtech specialising in transforming the future of risk selection, pricing and claims using the latest developments in data analytics, AI, machine learning, and digitalisation. Concirrus' intelligence platform Quest, helps organisations improve loss ratios, reduce operational expense and access increased deal sizes, and new trading relationships. By capturing and understanding customer behaviour, delivering data-rich insights at scale, underwriting teams are empowered to make rapid data-driven decisions. Over 20 market-leading companies including Marsh, Beazley, Hiscox, Chaucer and Willis Re trust Concirrus’ technology to power their risk making decisions. Headquartered in London with international presence, Concirrus has a 100-strong team of experts that specialise in data analytics, AI and machine learning, as well as having a rich understanding of the global insurance market.
Cardian
Seed Round in 2017
Cardian has been formed to commercialise a novel implantable device that improves the monitoring and treatment of cardiac failure patients, by providing completely automated, continuous wireless monitoring of blood pressure in the pulmonary artery. Following this investment, Innovations will hold a 53.7% interest in the Company, comprising a combination of founders equity and 27.3% derived from investment.
Cortexica is a London based, global service provider of practical AI solutions for businesses. Providing clarity and insight from within the noise around AI, Cortexica delivers world-leading Computer Vision image recognition and search technologies supported by industry specific consultancy. Working with clients across a range of verticals including retail, media, manufacturing and pharmaceuticals, Cortexica’s technology is robust and flexible and can be integrated to any requirements on any system or platform, including on device. The ability to partner with clients to create AI solutions for their specific needs, from innovation to delivery, ensures maximum benefit and return on investment. Cortexica was developed from the Bioengineering Department of Imperial College London, and originated from a pioneering research to reverse-engineer the human visual cortex.
Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.
Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.
Resolver is a unique, independent online resolution service. We offer one place and one process to connect consumers directly to the people who can resolve their customer service issues. Our system is focused on communication and fair, efficient resolution. We help consumers get their voices heard effectively, so businesses get their issues resolved more efficiently. This way, the consumer is happy with the outcome and the business retains the customer. The Resolver platform offers fully online, end-to-end arbitration and dispute resolution, providing a fast and cost-efficient way to resolve disputes between two third parties. For businesses, Resolver offers value-added services, providing an enhanced issue-resolution process and real-time consumer feedback insight at every touchpoint using advanced AI programming systems.
Garrison Technology Limited develops technologies for enterprise cybersecurity needs. The company was incorporated in 2014 and is based in London, United Kingdom. It aims to serve the growing enterprise market with its anti-malware product. It wants to address the large and growing enterprise cyber security market. The company has pioneered in an anti-malware product that efficiently sidesteps the highest impact cyber threats to modern organizations, i.e. internet-borne targeted attacks. Due to Garrison’s unique technology, a previously inconceivable brand of ultra-secure internet connectivity, user experience, and enterprise scalability can be achieved.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
ApcinteX develops and markets anticoagulant APC pathway to treat haemophilia. Apcintex has developed a new treatment that seeks to turn down the activity of a key natural anticoagulant pathway to produce normal blood clotting in patients with haemophilia. This means that the drug could potentially treat patients with all types of haemophilia, including those who develop antibodies to replacement factors. Furthermore, the drug does not cause anti-clotting antibodies to form and could be administered fortnightly by simple injection under the skin.
Concirrus is a leading Insurtech specialising in transforming the future of risk selection, pricing and claims using the latest developments in data analytics, AI, machine learning, and digitalisation. Concirrus' intelligence platform Quest, helps organisations improve loss ratios, reduce operational expense and access increased deal sizes, and new trading relationships. By capturing and understanding customer behaviour, delivering data-rich insights at scale, underwriting teams are empowered to make rapid data-driven decisions. Over 20 market-leading companies including Marsh, Beazley, Hiscox, Chaucer and Willis Re trust Concirrus’ technology to power their risk making decisions. Headquartered in London with international presence, Concirrus has a 100-strong team of experts that specialise in data analytics, AI and machine learning, as well as having a rich understanding of the global insurance market.
Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.